Reports for TEVA CANADA LIMITED

Formerly known as ACTAVIS PHARMA COMPANY

Company Name
TEVA CANADA LIMITED

Shortage reports

Actual shortage:

285 (9%)

Anticipated shortage:

1 (0%)

Avoided shortage:

10 (0%)

Resolved:

3009 (91%)

3305

Discontinuation Reports

To be discontinued:

2 (0%)

Discontinued:

411 (94%)

Reversed:

23 (5%)

436

485 (13%)

40 (14%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ACT BORTEZOMIB 3.5MG POWDER FOR SOLUTION Resolved 2020-01-30 2020-05-29 104930
ACT BORTEZOMIB 3.5MG POWDER FOR SOLUTION Actual shortage 2025-01-23 2026-03-17 248442
ACT BUPRENORPHINE/NALOXONE 8MG 2MG TABLET Resolved 2019-09-26 2020-01-24 94896
ACT BUPRENORPHINE/NALOXONE 2MG 0.5MG TABLET Resolved 2019-10-03 2020-01-24 95396
ACT BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2020-04-23 2020-05-08 113043
ACT BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2020-05-01 2020-05-08 113726
ACT BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2020-06-25 2021-04-29 118960
ACT BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2018-12-04 2019-10-17 68569
ACT BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2018-12-04 2019-10-10 68572
ACT BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2018-12-04 2020-02-13 68577
ACT BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2018-12-04 2019-11-22 68580
ACT BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2020-04-03 2020-05-08 110797
ACT CABERGOLINE 0.5MG TABLET Actual shortage 2017-05-03 2026-03-17 8767
ACT CELECOXIB 200MG CAPSULE Actual shortage 2021-02-18 2021-05-06 134357
ACT CELECOXIB 100MG CAPSULE Resolved 2019-08-22 2020-03-12 92235
ACT CELECOXIB 200MG CAPSULE Resolved 2020-03-06 2020-09-03 107998
ACT CELECOXIB 200MG CAPSULE Resolved 2021-01-22 2021-02-12 132291
ACT CELECOXIB 100MG CAPSULE Resolved 2019-08-22 2021-02-12 92232
ACT CELECOXIB 100MG CAPSULE Resolved 2021-01-28 2021-02-12 132669
ACT CELECOXIB 200MG CAPSULE Resolved 2018-12-04 2019-04-11 68583

Showing 21 to 40 of 3305

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-LISINOPRIL/HCTZ (TYPE P) 12.5MG 10MG TABLET Discontinued 2018-10-12 2018-10-12 63975
TEVA-LORAZEPAM 1MG TABLET Discontinued 2025-05-28 2025-05-28 258513
TEVA-LOSARTAN/HCTZ 50.0MG 12.5MG TABLET Discontinued 2021-02-12 2021-02-12 133902
TEVA-LOSARTAN/HCTZ 100MG 25MG TABLET Discontinued 2021-02-12 2021-02-12 133899
TEVA-LOSARTAN/HCTZ 100MG 12.5MG TABLET Discontinued 2021-02-12 2021-02-12 133896
TEVA-MEDROXYPROGESTERONE 2.5MG TABLET Discontinued 2025-04-29 2025-04-29 256113
TEVA-MEDROXYPROGESTERONE 5MG TABLET Discontinued 2025-04-29 2025-04-29 256116
TEVA-MEDROXYPROGESTERONE 10MG TABLET Discontinued 2025-04-29 2025-04-29 256119
TEVA-METFORMIN 850MG TABLET Reversed 2025-05-28 2025-06-04 258449
TEVA-METFORMIN 500MG TABLET Reversed 2025-05-28 2025-06-04 258452
TEVA-METOPROLOL 100MG TABLET Discontinued 2025-05-28 2025-05-28 258537
TEVA-METOPROLOL 100MG TABLET Discontinued 2025-05-28 2025-05-28 258568
TEVA-METOPROLOL 50MG TABLET Discontinued 2020-07-10 2020-07-10 119976
TEVA-MIRTAZAPINE 30MG TABLET Discontinued 2024-10-11 2024-10-11 240081
TEVA-MIRTAZAPINE 30MG TABLET Discontinued 2025-03-20 2025-03-20 253165
TEVA-MIRTAZAPINE 30MG TABLET Discontinued 2021-02-12 2021-02-12 133908
TEVA-MIRTAZAPINE 30MG TABLET Discontinued 2025-05-28 2025-05-28 258535
TEVA-MIRTAZAPINE 30MG TABLET Reversed 2025-05-28 2025-06-04 258532
TEVA-MODAFINIL 100MG TABLET Discontinued 2025-05-28 2025-05-28 258732
TEVA-NAPROXEN 375MG TABLET Discontinued 2025-05-28 2025-05-28 258493